Back to Search
BERNARD GRAN, M.D.
M.D.
Neurology Physician
NPI: 1285602078IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
ME0030639(FL)
CMS Specialties
PrimaryNEUROLOGY
Education
UNIVERSITY OF MIAMI, LM MILLER SCHOOL OF MEDICINE
Class of 1976
Research & Publications (20)
Modulation of regulatory T cells in health and disease: role of toll-like receptors.
PMID 19530994·Inflamm Allergy Drug Targets·2009
6-review
Atypical progressive multifocal leukoencephalopathy associated with an unusual JC polyomavirus mutation.
PMID 19667225·Arch Neurol·2009
5-case
Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis.
PMID 18544456·J Neurol Sci·2008
7-preclinical
Inducible IL-23p19 expression in human microglia via p38 MAPK and NF-kappaB signal pathways.
PMID 18054783·Exp Mol Pathol·2008
8-other
Role of the innate immune system in autoimmune inflammatory demyelination.
PMID 18473806·Curr Med Chem·2008
6-review
Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells.
PMID 17994023·Nat Immunol·2007
7-preclinical
Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis.
PMID 17709543·J Immunol·2007
7-preclinical
The PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma.
PMID 17320975·J Neuroimmunol·2007
7-preclinical
Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia.
PMID 17003070·Brain·2007
8-other
The protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis.
PMID 17262995·Mult Scler·2006
7-preclinical
Cutting Edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta.
PMID 17114417·J Immunol·2006
7-preclinical
Pathophysiology of interleukin-23 in experimental autoimmune encephalomyelitis.
PMID 16628262·Drug News Perspect·2006
6-review
Loss of the surface antigen 3G11 characterizes a distinct population of anergic/regulatory T cells in experimental autoimmune encephalomyelitis.
PMID 16517704·J Immunol·2006
7-preclinical
Glucosamine abrogates the acute phase of experimental autoimmune encephalomyelitis by induction of Th2 response.
PMID 16301624·J Immunol·2005
7-preclinical
IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis.
PMID 15850576·J Neurol Sci·2005
7-preclinical
A paradoxical role of APCs in the induction of intravenous tolerance in experimental autoimmune encephalomyelitis.
PMID 15748949·J Neuroimmunol·2005
4-observational
T cell and antibody responses in remitting-relapsing experimental autoimmune encephalomyelitis in (C57BL/6 x SJL) F1 mice.
PMID 14975581·J Neuroimmunol·2004
4-observational
Role of the IL-12/IL-23 system in the regulation of T-cell responses in central nervous system inflammatory demyelination.
PMID 15581393·Crit Rev Immunol·2004
6-review
Early administration of IL-12 suppresses EAE through induction of interferon-gamma.
PMID 15465603·J Neuroimmunol·2004
4-observational
Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis.
PMID 14568921·J Immunol·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9055 SW 87TH AVE STE 100
MIAMI, FL 33176 - Phone
- (305) 596-2080
Quick Facts
- NPI
- 1285602078
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 50
- Publications
- 20
Are you this provider?
Claim Your Profile